Breaks Categories: News

ThursdayMar 16, 2017 9:54 am

NetworkNewsBreaks – eXp World Holdings, Inc. (EXPI) Reaches 3,000 Agents through eXp Realty LLC

eXp World Holdings, Inc. (OTCQB: EXPI), holding company for the Agent-Owned Cloud Brokerage®, this morning announced that eXp Realty’s family of agents and brokers now includes more than 3,000 members across its operating markets in the United States and Canada. This figure represents a 25 percent increase from the company’s total of 2,401 agents at the end of 2016, as well as an increase of more than 200 percent year-over-year. “eXp Realty continues to attract an increasing number of top agents, teams and brokers, which has catapulted us to a place alongside the top residential brokerage firms in the country,”…

Continue Reading

ThursdayMar 16, 2017 9:30 am

NetworkNewsBreaks – Social Reality, Inc. (NASDAQ: SRAX) to Host 2016 Financial Results Conference Call on March 30

Internet advertising company Social Reality, Inc. (NASDAQ: SRAX) this morning announced plans to host a conference call discussing its fourth quarter 2016 financial results at 1:30 pm PT on March 30, 2017. In addition to giving prospective investors a financial and operational summary of SRAX’s progress during 2016, CEO Christopher Miglino and CFO J.P. Hannan are expected to offer insight into the company’s vision for the coming months during the call. To access the conference call, investors should dial (877) 681-3372 if calling from the United States or Canada, or (719) 325-4907 if calling internationally. The passcode for both numbers…

Continue Reading

TuesdayMar 14, 2017 11:12 am

NetworkNewsBreaks – TapImmune, Inc. (NASDAQ: TPIV) HER2-Targeted Vaccine to be Evaluated in Phase 2 Study Funded by US Department of Defense

Clinical-stage immuno-oncology company TapImmune, Inc. (NASDAQ: TPIV) this morning announced that its collaborators at the Mayo Clinic recently received a $3.7 million grant from the U.S. Department of Defense (DoD) to conduct a Phase 2 clinical study on the company’s HER2/neu-targeted T-cell vaccine. The DoD-funded study will evaluate women diagnosed with an early form of breast cancer called ductal carcinoma in situ (DCIS), and, if successful, could clear the way for TapImmune’s vaccine to replace standard surgery and chemotherapy by becoming part of a routine immunization schedule for preventing breast cancer in healthy women. “This is our second T-cell vaccine…

Continue Reading

TuesdayMar 14, 2017 10:12 am

NetworkNewsBreaks – SinglePoint, Inc. (SING) Expands Presence in Cannabis Industry through Acquisition of Stake in Convectium

Specialized holding company SinglePoint, Inc. (OTC: SING) this morning announced that it has closed its first round of funding to acquire a stake in Jacksam Corp., dba Convectium, the developer of a unique oil filling system poised to revolutionize the cannabis industry. Originally announced at the end of January, the Convectium acquisition is expected to include an overall investment of stock and cash consideration totaling $800,000, which Convectium will use to help fund its growth as well as marketing of its revolutionary 710Shark and 710Seal system. Leaning on the marketability of the first-of-its-kind system, as well as its line of…

Continue Reading

TuesdayMar 14, 2017 9:22 am

NetworkNewsBreaks – GreeneStone Healthcare Corp. (GRST) Announces Engagement of NetworkNewsWire

Healthcare services company GreeneStone Healthcare Corp. (OTCQB: GRST) this morning announced its engagement of NetworkNewsWire (“NNW”), a multifaceted financial news and publishing company that delivers a new generation of social communication solutions, news aggregation and syndication, and enhanced news release services. Leveraging an investor-based distribution network that includes more than 5,000 key syndication outlets, various newsletters, numerous social media channels, blogs, and other outreach tools, NNW will look to generate greater brand awareness for GreeneStone as it works to expand its presence in the U.S. treatment market through its newly-acquired facility in Delray Beach, Florida. “We are pleased to partner…

Continue Reading

MondayMar 13, 2017 1:45 pm

NetworkNewsBreaks – Bridgeline Digital, Inc. (NASDAQ: BLIN) Adds Intranet Services to Engagement with National Shipping and Business Franchise Customer

Bridgeline Digital, Inc. (NASDAQ: BLIN) announced today that one of the nation’s largest franchise systems of retail shipping, postal, print and business service centers has launched a new corporate intranet powered by Bridgeline Digital’s enterprise solutions. The company currently powers the customer’s public facing website. This engagement includes a 3-year SaaS license with the total value of license and services estimated at over $500,000. The intranet further delivers for the distribution of training materials, front end user management and single sign-on for employees and franchisees, as well as a dynamic activity stream, real time connect, and the ability to define…

Continue Reading

MondayMar 13, 2017 12:21 pm

NetworkNewsBreaks – BlackStar Enterprise Group, Inc. (BEGI) Announces Engagement of NetworkNewsWire

Merchant banking and finance company BlackStar Enterprise Group, Inc. (OTC: BEGI) this morning announced its engagement of NetworkNewsWire (“NNW”), a multifaceted financial news and publishing company that delivers a new generation of social communication solutions, news aggregation and syndication, and enhanced news release services. Leveraging an investor-based distribution network that includes more than 5,000 key syndication outlets, various newsletters, numerous social media channels, blogs, and other outreach tools, NNW will look to generate greater brand awareness for BlackStar as it continues to offer investment and financing services to early stage companies exhibiting the potential for sustained growth. “We are a…

Continue Reading

MondayMar 13, 2017 11:34 am

NetworkNewsBreaks – ProBility Media Corp. (PBYA) Announces Engagement of NetworkNewsWire

Education technology company ProBility Media Corp. (OTCQB: PBYA) this morning announced its engagement of NetworkNewsWire (“NNW”), a multifaceted financial news and publishing company that delivers a new generation of social communication solutions, news aggregation and syndication, and enhanced news release services. Leveraging an investor-based distribution network that includes more than 5,000 key syndication outlets, various newsletters, numerous social media channels, blogs, and other outreach tools, NNW will look to generate greater brand awareness for ProBility Media as the company seeks to expand its presence in the sizable education technology market. “As a leading innovator in the EdTech space, we operate…

Continue Reading

MondayMar 13, 2017 10:44 am

NetworkNewsBreaks – Heat Biologics’ (NASDAQ: HTBX) Lung Cancer Trial Achieves Efficacy Endpoint, Advances to Phase 2; Shares Surge

Heat Biologics (NASDAQ: HTBX) is continuing a pre-market rally, currently up 20% following the company’s announcement that its phase 1b trial evaluating HS-110 in combination with Bristol-Myers Squibb’s (NYSE: BMY) nivolumab (Opdivo®) for the treatment of non-small cell lung cancer (NSCLC) has achieved the efficacy endpoint. Additionally, 5 out of 15 patients treated with the HS-110/nivolumab combination had 20% or greater tumor reduction. Upon review, the Data Monitoring Committee (DMC) determined that the positive safety profile, mechanistic evidence and encouraging signs of synergistic efficacy warranted expansion to a phase 2 trial. “We designed this trial with the Bristol-Myers Squibb Checkmate…

Continue Reading

FridayMar 10, 2017 11:06 am

NetworkNewsBreaks – Endocyte, Inc. (NASDAQ: ECYT) Partners with Seattle Children’s Research Institute to Develop Endocyte’s SMDC Bi-Specific Adaptors for CAR T-cell Therapies

Shares of Endocyte (NASDAQ: ECYT) are up 10% following the company’s early announcement of its collaboration with Seattle Children’s Research Institute and Dr. Michael Jensen. The partnership will develop Endocyte’s SMDC platform in the chimeric antigen receptor T-cell (CAR T-cell) immunotherapy setting through the use of Endocyte’s proprietary SMDC bi-specific adaptor molecules. The goal of the research collaboration is to move these potentially enabling technologies more quickly to patients in the clinic. “This partnership brings together Dr. Jensen’s expertise in the discovery and development of CAR T-cell therapies and Endocyte’s SMDC platform, with the aim of improving the efficacy and…

Continue Reading